Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-trace').style.display = (document.getElementById('cakeErr680559d23f50b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680559d23f50b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-code').style.display = (document.getElementById('cakeErr680559d23f50b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-context').style.display = (document.getElementById('cakeErr680559d23f50b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680559d23f50b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680559d23f50b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21440,
		&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21587,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21440,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21440,
	&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21587,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21440
$metaTitle = &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;
$metaKeywords = &#039;Tuberculosis,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Spectre of drug shortage over TB treatment -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.</p><p align="justify">Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.</p><p align="justify">Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;</p><p align="justify">Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.</p><p align="justify">&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.</p><p align="justify">Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.</p><p align="justify">The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.</p><p align="justify">While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.</p><p align="justify">Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-trace').style.display = (document.getElementById('cakeErr680559d23f50b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680559d23f50b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-code').style.display = (document.getElementById('cakeErr680559d23f50b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-context').style.display = (document.getElementById('cakeErr680559d23f50b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680559d23f50b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680559d23f50b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21440,
		&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21587,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21440,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21440,
	&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21587,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21440
$metaTitle = &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;
$metaKeywords = &#039;Tuberculosis,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Spectre of drug shortage over TB treatment -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.</p><p align="justify">Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.</p><p align="justify">Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;</p><p align="justify">Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.</p><p align="justify">&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.</p><p align="justify">Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.</p><p align="justify">The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.</p><p align="justify">While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.</p><p align="justify">Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-trace').style.display = (document.getElementById('cakeErr680559d23f50b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680559d23f50b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-code').style.display = (document.getElementById('cakeErr680559d23f50b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680559d23f50b-context').style.display = (document.getElementById('cakeErr680559d23f50b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680559d23f50b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680559d23f50b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21440,
		&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21587,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21440,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21440,
	&#039;title&#039; =&gt; &#039;Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21587,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21440
$metaTitle = &#039;LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee&#039;
$metaKeywords = &#039;Tuberculosis,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &amp;quot;In our project in Nagaland, I&#039;ve seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days&#039; drugs available from a patient who had died. Otherwise, we&#039;re having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In this instance, it&#039;s a stock-out that can cost people&#039;s lives and the government must act urgently to fix the problems,&amp;quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world&#039;s highest rates of DR-TB.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world&#039;s second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Spectre of drug shortage over TB treatment -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.</p><p align="justify">Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.</p><p align="justify">Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;</p><p align="justify">Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.</p><p align="justify">&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.</p><p align="justify">Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.</p><p align="justify">The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.</p><p align="justify">While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.</p><p align="justify">Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 21440,
		'title' => 'Spectre of drug shortage over TB treatment -Rupali Mukherjee',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<br />
<em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
</p>
<p align="justify">
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
</p>
<p align="justify">
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;
</p>
<p align="justify">
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
</p>
<p align="justify">
&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
</p>
<p align="justify">
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.
</p>
<p align="justify">
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
</p>
<p align="justify">
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
</p>
<p align="justify">
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
</p>',
		'credit_writer' => 'The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21587,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 21440,
	'metaTitle' => 'LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee',
	'metaKeywords' => 'Tuberculosis,Health',
	'metaDesc' => '
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.</p><p align="justify">Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.</p><p align="justify">Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;</p><p align="justify">Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.</p><p align="justify">&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.</p><p align="justify">Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.</p><p align="justify">The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.</p><p align="justify">While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.</p><p align="justify">Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 21440,
	'title' => 'Spectre of drug shortage over TB treatment -Rupali Mukherjee',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<br />
<em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.
</p>
<p align="justify">
Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.
</p>
<p align="justify">
Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;
</p>
<p align="justify">
Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.
</p>
<p align="justify">
&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.
</p>
<p align="justify">
Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.
</p>
<p align="justify">
The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.
</p>
<p align="justify">
While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
</p>
<p align="justify">
Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. 
</p>',
	'credit_writer' => 'The Times of India, 18 June, 2013, http://timesofindia.indiatimes.com/india/Spectre-of-drug-shortage-over-TB-treatment/articleshow/20640118.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'spectre-of-drug-shortage-over-tb-treatment-rupali-mukherjee-21587',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21587,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 21440
$metaTitle = 'LATEST NEWS UPDATES | Spectre of drug shortage over TB treatment -Rupali Mukherjee'
$metaKeywords = 'Tuberculosis,Health'
$metaDesc = '
-The Times of India



MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say.</p><p align="justify">Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients.</p><p align="justify">Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: &quot;In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them.&quot;</p><p align="justify">Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance.</p><p align="justify">&quot;In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems,&quot; said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years.</p><p align="justify">Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB.</p><p align="justify">The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive.</p><p align="justify">While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.</p><p align="justify">Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Spectre of drug shortage over TB treatment -Rupali Mukherjee

-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for patients. Dr Homa Mansoor, the TB medical referent for MSF India - the international medical humanitarian organization- said: "In our project in Nagaland, I've seen a 12-year-old girl on treatment arrive with her father after a long journey to get her medicine. The medicines were out of stock, but luckily we had six days' drugs available from a patient who had died. Otherwise, we're having to resort to breaking adult pills to give to children, which is really dangerous as it could over- or under-dose them." Other patients have been forced to purchase medicines from private pharmacies, but have received lower-dosage drugs, which could lead to resistance. "In this instance, it's a stock-out that can cost people's lives and the government must act urgently to fix the problems," said Leena Menghaney, India manager of MSF. With clinics in Nagaland and Maharashtra, MSF has provided TB treatment for 25 years. Under the national TB treatment programme, the Centre is responsible for buying drugs and distributing them to states, which provide treatment. The stock-out is a result of the never-ending issues that plague drug procurement, sources said. The routine delay in tendering and the resultant drug stock-outs are some of the reasons why India has one of the world's highest rates of DR-TB. The country has one of the highest prevalence of TB, with one person dying of the disease every two minutes. Many patients simply go undiagnosed or are not treated in time. Besides, India also has the world's second highest multi-drug resistant tuberculosis (MDR-TB) rates, with nearly 66,000 new cases every year. Yet only 5% of the people diagnosed with the disease get the treatment they need to stay alive. While DR-TB refers to those strains of TB that show resistance to one or more first-line drugs, MDR-TB is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs. Though first-line TB drugs are not expensive and are available, treatment cost for DR-TB is huge at nearly $4,000 or Rs 3.87 lakh per patient per year. The problems that plague DR-TB medicines are limited number of quality suppliers, affordability and stock-outs.